Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 8 results:
Author Title [ Type(Desc)] Year
Filters: Author is Kuo, C. F.  [Clear All Filters]
Journal Article
C. F. Kuo, Grainge, M. J., Mallen, C., Zhang, W., and Doherty, M., Comorbidities in patients with gout prior to and following diagnosis: case-control study, Ann Rheum Dis, vol. 75, pp. 210-7, 2016.
I. J. Chou, Kuo, C. F., Tanasescu, R., Tench, C. R., Tiley, C. G., Constantinescu, C. S., and Whitehouse, W. P., Comorbidity in multiple sclerosis: its temporal relationships with disease onset and dose effect on mortality, Eur J Neurol, 2019.
C. F. Kuo, Grainge, M. J., Mallen, C., Zhang, W., and Doherty, M., Effect of allopurinol on all-cause mortality in adults with incident gout: propensity score-matched landmark analysis, Rheumatology (Oxford), vol. 54, pp. 2145-50, 2015.
C. F. Kuo, Grainge, M. J., Mallen, C., Zhang, W., and Doherty, M., Impact of gout on the risk of atrial fibrillation, Rheumatology (Oxford), vol. 55, pp. 721-8, 2016.
A. Abhishek, Nakafero, G., Kuo, C. F., Mallen, C., Zhang, W., Grainge, M. J., and Doherty, M., Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink, Rheumatology (Oxford), vol. 57, pp. 977-981, 2018.
A. Abhishek, Doherty, M., Kuo, C. F., Mallen, C. D., Zhang, W., and Grainge, M. J., Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study, Rheumatology (Oxford), vol. 56, pp. 736-744, 2017.
C. F. Kuo, Grainge, M. J., Mallen, C., Zhang, W., and Doherty, M., Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study, Ann Rheum Dis, vol. 74, pp. 661-7, 2015.
C. F. Kuo, Chou, I. J., See, L. C., Chen, J. S., Yu, K. H., Luo, S. F., Hsieh, A. H., Zhang, W., and Doherty, M., Urate-lowering treatment and risk of total joint replacement in patients with gout, Rheumatology (Oxford), vol. 57, pp. 2129-2139, 2018.
[Page last reviewed 4 October 2019]